C21 Investments Inc. Overview
Pro stress-test →C21 Investments Inc. is a Canada-based vertically integrated cannabis company that cultivates, processes and distributes cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals.
Strategic Profile
Pro stress-test →The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets with multi-market branded consumer packaged goods (CPG). In fiscal year 2025, C21 Investments's revenue was $30.12 million, an increase of 12.42% compared to the previous year's $26.79 million.
Competitive Landscape
Pro stress-test →C21 competes within the fragmented U.S. cannabis market against other vertically integrated operators and regional multi-state cannabis companies. The company's CPG-focused strategy and retail integration differentiate it from pure cultivation or distribution players, though regulatory uncertainty and OTC market constraints limit competitive reach versus larger MSOs.
Industry Context
C21 Investments Inc. operates in Multi-state cannabis cultivation and retail.
Key facts
Founded: 1987 · Headquarters: Vancouver, Canada · Employees: 138 · Revenue: $30.1M · Market cap: $28.4M